Cystic Fibrosis Transmembrane Conductance Regulator Modulators Reduce Hospitalizations for Acute Pancreatitis in Patients With Cystic Fibrosis

被引：0
|
作者：
Ramsey, M. L. [1 ]
Sobotka, L. A. [1 ]
Wellner, M. R. [1 ]
Porter, K. [2 ]
Lara, L. F. [1 ]
机构：
[1] Ohio State Univ, Div Gastroenterol Hepatol & Nutr, Wexner Med Ctr, Columbus, OH 43210 USA
[2] Ohio State Univ, Coll Med, Ctr Biostat, Dept Biomed Informat, Columbus, OH 43210 USA
来源：
PANCREAS | 2020年 / 49卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1425 / 1426
页数：2
相关论文
共 50 条
  • [1] Cystic fibrosis transmembrane conductance regulator modulators reduce the risk of recurrent acute pancreatitis among adult patients with pancreas sufficient cystic fibrosis
    Akshintala, Venkata S.
    Kamal, Ayesha
    Faghih, Mahya
    Cutting, Garry R.
    Cebotaru, Liudmila
    West, Natalie E.
    Jennings, Mark T.
    Dezube, Rebecca
    Whitcomb, David C.
    Lechtzin, Noah
    Merlo, Christian A.
    Singh, Vikesh K.
    PANCREATOLOGY, 2019, 19 (08) : 1023 - 1026
  • [2] Cystic Fibrosis Transmembrane Conductance Regulator Modulator Use Is Associated With Reduced Pancreatitis Hospitalizations in Patients With Cystic Fibrosis
    Ramsey, Mitchell L.
    Gokun, Yevgeniya
    Sobotka, Lindsay A.
    Wellner, Michael R.
    Porter, Kyle
    Kirkby, Stephen E.
    Li, Susan S.
    Papachristou, Georgios I.
    Krishna, Somashekar G.
    Stanich, Peter P.
    Hart, Phil A.
    Conwell, Darwin L.
    Lara, Luis F.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 (12): : 2446 - 2454
  • [3] EFFECT OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGUATOR MODULATORS ON RECURRENT ACUTE PANCREATITIS IN PATIENTS WITH CYSTIC FIBROSIS
    Ramsey, M. L.
    Sobotka, L. A.
    Porter, K.
    Wellner, M. R.
    Lara, L. F.
    PEDIATRIC PULMONOLOGY, 2020, 55 : S123 - S124
  • [4] The Extrapulmonary Effects of Cystic Fibrosis Transmembrane Conductance Regulator Modulators in Cystic Fibrosis
    Sergeev, Valentine
    Chou, Frank Y.
    Lam, Grace Y.
    Hamilton, Christopher Michael
    Wilcox, Pearce G.
    Quon, Bradley S.
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2020, 17 (02) : 147 - 154
  • [5] Cystic fibrosis transmembrane conductance regulator modulators: precision medicine in cystic fibrosis
    Burgener, Elizabeth B.
    Moss, Richard B.
    CURRENT OPINION IN PEDIATRICS, 2018, 30 (03) : 372 - 377
  • [6] Tritherapy with cystic fibrosis transmembrane conductance regulator protein modulators in cystic fibrosis
    Colodro, Oscar Fielbaum
    Grell, Alberto Vidal
    Yarur, Alejandra Mendez
    Clerc, Camila Sobarzo
    ANDES PEDIATRICA, 2022, 93 (06): : 898 - 905
  • [7] Cystic fibrosis transmembrane conductance regulator modulators in cystic fibrosis: current perspectives
    Schmidt, BeLa Z.
    Haaf, Jeremy B.
    Leal, Teresinha
    Noel, Sabrina
    CLINICAL PHARMACOLOGY-ADVANCES AND APPLICATIONS, 2016, 8 : 127 - 140
  • [8] Cystic fibrosis transmembrane conductance regulator modulators for cystic fibrosis: a new dawn?
    Edmondson, Claire
    Course, Christopher William
    Doull, Iolo
    ARCHIVES OF DISEASE IN CHILDHOOD, 2021, 106 (10) : 941 - 945
  • [9] EFFECT OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR MODULATORS ON DEVELOPMENT OF CIRRHOSIS IN PATIENTS WITH CYSTIC FIBROSIS
    Sobotka, Lindsay
    Ramsey, Mitchell L.
    Porter, Kyle
    Lara, Luis F.
    Wellner, Michael
    HEPATOLOGY, 2020, 72 : 356A - 357A
  • [10] Cystic fibrosis: bacterial pathogenesis and CFTR (cystic fibrosis transmembrane conductance regulator) modulators
    Vargas-Roldan, Silvia Y.
    Lezana-Fernandez, Jose L.
    Cerna-Cortes, Jorge F.
    Partida-Sanchez, Santiago
    Santos-Preciado, Jose, I
    Rosales-Reyes, Roberto
    BOLETIN MEDICO DEL HOSPITAL INFANTIL DE MEXICO, 2022, 79 (04): : 215 - 221
12345